Novo Nordisk rises as Hims & Hers backs down on oral GLP-1 Novo Nordisk's battered stock enjoyed a reprieve after Hims & Hers abandoned plans to launch a compounded version of the new Wegovy pill.

#NovoNordisk's battered stock enjoyed a moment of reprieve after #HimsandHers abandoned plans to launch a #compoundedversion of the just-launched #Wegovy pill.

pharmaphorum.com/news/novo-no...